Skip to main content
Ronald Chen, MD, Radiation Oncology, Kansas City, KS, University of North Carolina Hospitals

RonaldCChenMD

Radiation Oncology Kansas City, KS

Professor and Chair, University of Kansas, Kansas City, KS

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Chen's full profile

Already have an account?

Summary

  • Dr. Ronald Chen is a radiation oncologist in Kansas City, KS. He received his medical degree from Harvard Medical School and has been in practice 13 years. He is experienced in brachytherapy, prostate cancer, stereotactic radiosurgery, intensity-modulated radiation therapy, and radiosurgery.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2005 - 2009
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 2004 - 2005
  • Harvard Medical School
    Harvard Medical SchoolClass of 2004

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2022 - 2023
  • KS State Medical License
    KS State Medical License 2019 - 2023
  • MO State Medical License
    MO State Medical License 2019 - 2024
  • NC State Medical License
    NC State Medical License 2009 - 2020
  • MA State Medical License
    MA State Medical License 2006 - 2011
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Health Services Research, Clinical Informatics, and Quality of Care 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Quality-adjusted time without symptoms or toxicity (Q-TWiST): Analysis of cabozantinib (Cabo) vs sunitinib (Sun) in patients with advanced renal cell carcinoma (aRCC) ... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Frequency of post-treatment surveillance and survival in localized prostate cancer: AFT-30 a national study. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Press Mentions

  • Ronald Chen Named Chair of Radiation Oncology
    Ronald Chen Named Chair of Radiation OncologySeptember 19th, 2019
  • Patients and Their Records Agree on Medical History for Most Maladies
    Patients and Their Records Agree on Medical History for Most MaladiesFebruary 16th, 2017
  • Active Surveillance Underused in Prostate Cancer Patients Who Want to Preserve Sexual Function
    Active Surveillance Underused in Prostate Cancer Patients Who Want to Preserve Sexual FunctionDecember 13th, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations